Journal of Andrology Proceedings of the Fifth International Conference on the Epididymis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Right arrow Return to article

Table 3. Lipid effects during treatment in Chinese men who were randomly assigned to group I (4 LNG implants plus 500 mg of TU every 8 weeks); group II (4 LNG implants plus 1000 mg of TU every 8 weeks); group III (1000 mg of TU every 8 weeks){dagger}
      Treatment Week
  Recovery Week
    Baseline   4   12{ddagger}   20{ddagger}   28{ddagger}   8   16
  Total cholesterol (mg/dL)              
      Group I   164 ± 8.4   160 ± 8.9   149 ± 9.0   143 ± 8.2*   150 ± 8.3   169 ± 6.6   168 ± 7.2
      Group II   163 ± 9.0   13.8 ± 7.2*   139 ± 8.5*   138 ± 7.8*   142 ± 10.0*   169 ± 7.9   167 ± 7.0
      Group III   165 ± 7.2   ND   161 ± 8.0   154 ± 7.1   159 ± 9.5   164 ± 9.0   171 ± 7.7
  HDL cholesterol (mg/dL)              
      Group I   52 ± 3.2   48 ± 2.9   42 ± 3.4*   36 ± 2.7*   36 ± 2.7*   50 ± 3.5   49 ± 3.9
      Group II   48 ± 1.9   42 ± 1.8*   35 ± 2.1*   32 ± 2.2*   34 ± 2.0*   44 ± 2.5   47 ± 2.0
      Group III   51 ± 2.6   ND   46 ± 2.9   40 ± 2.4*   42 ± 1.8*   43 ± 2.0*   47 ± 1.5
  Triglycerides (mg/dL)              
      Group I   164 ± 8.4   160 ± 8.9   150 ± 9.0   144 ± 8.2   150 ± 8.3   169 ± 6.6   168 ± 7.3
      Group II   163 ± 9.0   138 ± 7.2   138 ± 8.5   138 ± 7.7   142 ± 10.0   169 ± 7.9   167 ± 7.0
      Group III   165 ± 7.2   ND   161 ± 8.0   154 ± 7.1   159 ± 9.5   163 ± 9.0   171 ± 7.7
  {dagger}LNG indicates levonorgestrel; TU, testosterone undecanoate; ND, not done; and HDL, high-density lipoprotein
  {ddagger}Weeks 8, 16, and 24 for group III
  *P < .05 compared to baseline





Right arrow Return to article

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS